The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
MH002, a rationally designed live microbial consortium, combines six well-characterized commensal strains to target disease-specific mechanisms
Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures
Elanco expects Befrena to launch in the US in the first half of 2026
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
Subscribe To Our Newsletter & Stay Updated
